Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.
about
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyGene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies.High CTLA-4 expression correlates with poor prognosis in thymoma patients.Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies.
P2860
Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Enhancement of antibody-depend ...... a new era in cancer treatment.
@en
type
label
Enhancement of antibody-depend ...... a new era in cancer treatment.
@en
prefLabel
Enhancement of antibody-depend ...... a new era in cancer treatment.
@en
P2093
P2860
P356
P1476
Enhancement of antibody-depend ...... a new era in cancer treatment.
@en
P2093
Atsushi Yonezawa
Cariad Chester
Holbrook E Kohrt
Narendiran Rajasekaran
P2860
P304
P356
10.2147/ITT.S61292
P577
2015-05-15T00:00:00Z